Emyria Limited (ASX:EMD)
0.0500
-0.0010 (-1.96%)
Mar 4, 2026, 3:47 PM AEST
Emyria Revenue
Emyria had revenue of 736.55K AUD in the half year ending June 30, 2025, a decrease of -14.39%. This brings the company's revenue in the last twelve months to 2.29M, up 29.34% year-over-year. In the fiscal year ending June 30, 2025, Emyria had annual revenue of 1.39M, down -36.68%.
Revenue (ttm)
2.29M
Revenue Growth
+29.34%
P/S Ratio
17.95
Revenue / Employee
n/a
Employees
n/a
Market Cap
41.13M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 1.39M | -807.97K | -36.68% |
| Jun 30, 2024 | 2.20M | 610.25K | 38.32% |
| Jun 30, 2023 | 1.59M | -229.93K | -12.62% |
| Jun 30, 2022 | 1.82M | -153.51K | -7.77% |
| Jun 30, 2021 | 1.98M | 962.46K | 94.97% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Mach7 Technologies | 33.79M |
| ImExHS | 29.00M |
| Beamtree Holdings | 28.90M |
| Resonance Health | 13.79M |
| PharmX Technologies | 7.65M |
| Vitasora Health | 5.01M |
| PainChek | 2.09M |
| Singular Health Group | 961.53K |